A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
Status:
Recruiting
Trial end date:
2023-05-20
Target enrollment:
Participant gender:
Summary
In this single-arm study, patient with cervical cancer who had recurrence of the pelvic wall
after surgery ± Abdominal aortic lymph node metastasis will be included to evaluate the
efficacy and safety of camrelizumab combined with concurrent chemoradiation and subsequent
maintenance therapy